[The treatment of obstructive hypertrophic myocardiopathy refractory to medical therapy].
Until a few years ago, therapy of refractory Hypertrophic Obstructive cardiomyopathy was mainly surgical--Morrow's myotomy/myectomy or mitral valve replacement. Despite the good results of these techniques, they are not free of mortality and morbidity. In the last years a new and promising therapy has been developed: the Dual Chamber Pacemaker. Technically easier and less invasive than surgery, this therapy has achieved better results and lower mortality and morbidity during the follow-up.
Cardim
N
N
Serviço de Cardiologia, Hospital de Pulido Valente, Lisboa.
Longo
S
S
Gouveia
D
D
Lousada
N
N
Rodrigues
M
M
Ferreira
T
T
Pereira
A T
AT
Correia
J M
JM
D002312:Cardiomyopathy, Hypertrophic / Q000628:therapy*; D006346:Heart Septum / Q000601:surgery; D006350:Heart Valve Prosthesis; D006801:Humans; D008943:Mitral Valve; D010138:Pacemaker, Artificial
Terapêutica da miocardiopatia hipertrófica obstrutiva refractária à terapêutica médica.